MOS.NYSEMosaic CO

8-K: Mosaic Q3 2025 Earnings Soar on Strong Brazil, Potash Performance

Sentiment:

Quarterly Results


The Mosaic Company reported strong third-quarter 2025 results with net income of $411 million and adjusted EBITDA of $806 million, driven by robust performance in Brazil and higher potash prices.

Better than expectedNet income of $411 million and adjusted EBITDA of $806 million significantly exceeded prior year results (Q3 2024 net income $122 million, adjusted EBITDA $448 million).Mosaic Fertilizantes operating income increased 71% and adjusted EBITDA increased 190% versus the prior year quarter, indicating strong outperformance in a key region.Phosphate production volumes showed a third consecutive quarter of improvement, indicating successful resolution of previously reported operational issues.Potash production volumes are trending towards a record level in 2025, reflecting strong market conditions and operational efficiency.SG&A expenses decreased significantly due to lower bad debt expenses, indicating improved financial health and risk management.

Summary

  • Net income for Q3 2025 was $411 million, with diluted EPS of $1.29.
  • Adjusted EBITDA reached $806 million, and adjusted EPS was $1.04 for the quarter.
  • Net sales increased to $3.5 billion in Q3 2025, up from $3.0 billion in Q2 2025 and $2.8 billion in Q3 2024.
  • Operating earnings significantly improved to $340 million, compared to $244 million in Q2 2025 and $115 million in Q3 2024.
  • Mosaic Fertilizantes' operating income increased 71% to $96 million, and adjusted EBITDA surged 190% to $241 million year-over-year.
  • Phosphate production volumes improved for the third consecutive quarter, reaching 1.7 million tonnes in Q3 2025 and approximately 1.8 million tonnes for the trailing three months ending October.
  • Potash production volumes are trending towards a record level in 2025.
  • The company completed the sale of the Patos de Minas mine for $111 million and the Taquari potash mine for $27 million, generating $63 million in immediate proceeds and eliminating future capital investments and asset retirement obligations.
  • Mosaic Biosciences product sales more than doubled in the first nine months of 2025 compared to 2024, with full-year sales expected to exceed $70 million and contribute positively to adjusted EBITDA in Q4.

Sentiment

Score: 8

Explanation: The company delivered strong financial results with significant year-over-year growth in net income, adjusted EBITDA, and segment-specific performance, particularly in Brazil and Potash. Operational improvements in Phosphate production are noted, and strategic asset sales are complete. While free cash flow was negative and cash costs in Phosphate increased due to asset health initiatives, these are largely explained and expected to improve. The overall market outlook for fertilizers remains constructive, and the Biosciences segment shows promising growth. The positive impact of the Ma'aden share gain is a notable one-time item, but underlying operational improvements are evident.

Positives

  • Net income of $411 million and adjusted EBITDA of $806 million in Q3 2025 represent strong earnings despite market challenges.
  • Mosaic Fertilizantes showed significant growth with operating income up 71% to $96 million and adjusted EBITDA up 190% to $241 million compared to the prior year quarter.
  • Phosphate production volumes improved for the third consecutive quarter, reaching 1.7 million tonnes in Q3 2025 and 1.8 million tonnes for the trailing three months ending October.
  • Potash production volumes are on track for a record year in 2025, driven by strong global demand and higher prices.
  • The sale of Patos de Minas and Taquari mines generated $63 million in immediate proceeds and will eliminate over $25 million in capital investments and $22 million in asset retirement obligations.
  • Selling, general and administrative (SG&A) expenses decreased to $126 million, primarily due to lower bad debt expenses.
  • Mosaic Biosciences sales more than doubled in the first nine months of 2025 and are projected to reach $70 million for the full year, with a positive contribution to adjusted EBITDA in Q4.
  • Global fertilizer markets remain balanced to tight, supporting prices, with strong demand in Canpotex markets, China, Brazil, and Southeast Asia.
  • Chinese phosphate fertilizer exports are expected to fall more than 1.5 million tonnes this year, tightening the market into 2026.
  • Recovered $27 million of prior bad debt expense in Mosaic Fertilizantes with no material new bad debt expense recorded.

Negatives

  • Free cash flow in Q3 2025 was negative $(135) million, a decrease from $72 million in the same quarter last year.
  • Cash flow from operations decreased to $229 million in Q3 2025 from $313 million in Q3 2024, primarily due to higher working capital.
  • Capital expenditures increased to $364 million in Q3 2025 from $241 million in Q3 2024, driven by higher sustaining capex in Phosphate.
  • Phosphate cash cost of conversion per tonne increased to $131 in Q3 2025, up from $101 in Q3 2024 and $126 in Q2 2025, due to considerable costs associated with asset health initiatives in July.
  • Mosaic Fertilizantes sales volumes decreased slightly year-over-year due to softer fertilizer shipments amid a challenging credit environment in Brazil.
  • The Q4 2025 outlook for Mosaic Fertilizantes expects segment adjusted EBITDA to be approximately $100 million, lower than Q3, due to continuing credit constraints, lower selling prices, and higher raw material costs.
  • Potential demand deferral in North America for both potash and phosphate from winter fill to spring.
  • A $75 million loss was incurred on the treatment of the Taquari mine as an asset held for sale.

Risks

  • Political and economic instability and changes in government policies in countries where operations exist.
  • Predictability and volatility of agriculture, fertilizer, raw material, energy, and transportation markets, subject to competitive pressures and economic/credit market conditions.
  • The level of inventories in the distribution channels for crop nutrients.
  • The effect of future product innovations or development of new technologies on demand for products.
  • Changes in foreign currency and exchange rates.
  • International trade risks, including the impact of U.S. tariffs and retaliatory tariffs on economic conditions.
  • A material adverse change in the Ma'aden investment regarding financial position, performance, operations, or prospects.
  • Customer defaults.
  • The effects of decisions to exit business operations or locations.
  • Changes in government policy and environmental regulation, including expansion of water resources regulation, carbon taxes, greenhouse gas regulation, and numeric water quality standards.
  • Further developments in judicial or administrative proceedings, or complaints that operations adversely impact nearby farms, businesses, or properties.
  • Difficulties or delays in receiving, increased costs of, or challenges to necessary governmental permits or approvals, or increased financial assurance requirements.
  • Resolution of global tax audit activity.
  • The effectiveness of processes for managing strategic priorities.
  • Adverse weather conditions affecting operations in Central Florida, the Mississippi River basin, the Gulf Coast of the United States, Canada, or Brazil, including potential hurricanes, excess heat, cold, snow, rainfall, or drought.
  • Actual costs of various items differing from management's current estimates, including asset retirement, environmental remediation, reclamation, Canadian resources taxes and royalties, reduction of available cash and liquidity, and increased leverage.
  • Brine inflows at potash mines.
  • Other accidents and disruptions involving operations, including potential mine fires, floods, explosions, seismic events, sinkholes, or releases of hazardous or volatile chemicals.
  • Risks associated with cyber security, including reputational loss.

Future Outlook

Mosaic expects 2025 potash production volumes to be in the range of 9.1 to 9.4 million tonnes, with Q4 sales volumes between 2.3 and 2.6 million tonnes and MOP prices of $270 to $280 per tonne. Phosphate sales volumes for Q4 2025 are projected to be 1.7 to 1.9 million tonnes, with DAP prices averaging $700 to $730 per tonne. Mosaic Fertilizantes anticipates 2025 sales volumes between 9.4 and 9.6 million tonnes, though Q4 sales are expected to be slightly lower due to seasonality, with Q4 segment adjusted EBITDA around $100 million due to credit constraints. Mosaic Biosciences sales are expected to more than double to approximately $70 million in 2025 and contribute positively to adjusted EBITDA in the fourth quarter. Studies for the Niobium opportunity in Brazil are expected to be completed early next year, with re-engagement with interested parties in the first half of 2026. Global fertilizer markets are expected to remain balanced to tight, with strong demand for both phosphate and potash continuing into 2026, supported by reduced Chinese phosphate exports.

Management Comments

  • Mosaic generated strong earnings despite operational and market challenges in the third quarter.
  • Our business in Brazil continued to perform well while navigating the ongoing credit issues in Brazilian agriculture, and we delivered solid performance in our potash business, as strong global demand pushed prices higher.
  • In phosphates, our work to restore asset health has led to three consecutive months of higher production, and now we are focused on driving further improvements and sustainably higher operating rates.
  • With global market access as a strategic advantage, we have the ability to capitalize on constructive agricultural and fertilizer market trends and adapt to shifting market dynamics.

Industry Context

The announcement reflects a dynamic global agricultural market where fertilizer demand remains strong, particularly in key Canpotex markets, China, Brazil, and Southeast Asia. Despite trade uncertainty in North America and credit issues in Brazilian agriculture, improved commodity prices are expected to encourage fertilizer activity. The phosphate market is tightening due to growing demand (including for LFP batteries), limited new capacity, and reduced Chinese exports, which is a significant tailwind. Potash markets are balanced after a first-half supply deficit, with global demand expected to reach record levels. Mosaic's strategic asset sales and focus on operational improvements position it to capitalize on these constructive market trends, while its Biosciences platform taps into the growing demand for sustainable agricultural solutions.

Comparison to Industry Standards

  • The strong performance of Mosaic Fertilizantes, with operating income up 71% and adjusted EBITDA up 190% year-over-year, indicates robust regional outperformance despite challenging credit conditions in Brazil, potentially exceeding the average growth rates of competitors operating in similar emerging markets.
  • Potash production volumes trending towards a record level in 2025, coupled with strong global demand and higher prices, suggests Mosaic is effectively capturing market share and benefiting from favorable market dynamics, potentially outperforming peers with less diversified geographic reach like Nutrien or K+S.
  • The tightening phosphate market, driven by growing demand for fertilizer and LFP batteries, limited new capacity, and reduced Chinese exports (expected to fall over 1.5 million tonnes), provides a strong competitive advantage for established producers like Mosaic compared to smaller players or those reliant on Chinese supply.
  • The company's ability to recover $27 million of prior bad debt expense in Brazil and record no material new bad debt expense in Q3, while competitors might still be grappling with credit issues, demonstrates effective risk management in a challenging market.

Stakeholder Impact

  • Shareholders: Positive impact from strong earnings, increased adjusted EBITDA, and a consistent dividend payment of $0.22 per share. Strategic asset sales are expected to improve capital efficiency and reduce future obligations. The unrealized gain on Ma'aden shares also benefits equity.
  • Employees: Continued focus on operational improvements and asset health initiatives may lead to stable or increased employment in production facilities.
  • Customers: Improved production volumes in Phosphate and strong global supply for Potash ensure product availability. However, challenging credit environments in Brazil and potential demand deferrals in North America could impact some customer segments.
  • Creditors: The company's strong earnings and strategic divestitures could improve its financial position, potentially enhancing creditworthiness, although free cash flow was negative in the quarter.
  • Suppliers: Increased production volumes and capital expenditures suggest continued demand for raw materials and services.

Next Steps

  • Complete studies to better define the Niobium opportunity at Patrocinio and Araxa phosphate operations early next year.
  • Re-engage interested parties to discuss strategic alternatives for the Niobium opportunity in the first half of 2026.
  • Launch an additional Mosaic Biosciences product in 2025.
  • Continue driving further improvements and sustainably higher operating rates in the Phosphate segment.
  • Monitor and adapt to shifting market dynamics and credit issues in Brazilian agriculture.
  • Engage with interested parties to advance strategic alternatives for the Carlsbad, New Mexico potash mine.

Key Dates

DateDescription
2025-09-30End of the third quarter for which earnings and results of operations are reported.
2025-10-01Completion of the sale of the Patos de Minas mine.
2025-11-01Completion of the sale of the Taquari potash mine.
2025-11-04Date of the 8-K report and press release issuance regarding Q3 2025 earnings.
2025-11-05Conference call to discuss third quarter 2025 earnings results.
2026-01-01Expected completion of studies to better define the Niobium opportunity at Patrocinio and Araxa phosphate operations.
2026-07-01Expected re-engagement with interested parties to discuss strategic alternatives for Niobium opportunity in the first half of 2026.

Recommendation

buy

The Mosaic Company's Q3 2025 results demonstrate significant operational and financial strength, with net income and adjusted EBITDA showing substantial year-over-year growth. The robust performance of Mosaic Fertilizantes and the Potash segment, coupled with improving Phosphate production, indicates effective management and a strong market position. Strategic asset divestitures are enhancing capital efficiency and reducing future liabilities. While free cash flow was negative due to working capital timing and increased capex, these are largely temporary factors, and cash flow from operations is expected to improve. The positive outlook for global fertilizer markets, driven by strong demand and tightening supply (especially in phosphates due to Chinese export reductions), provides a favorable environment for continued growth. The promising trajectory of Mosaic Biosciences further diversifies revenue streams. Given the strong underlying business performance, strategic initiatives, and constructive market fundamentals, the stock presents a compelling 'buy' opportunity for investors seeking exposure to the agricultural commodities sector.

Keywords

Fertilizer, Phosphate, Potash, Crop Nutrients, Agriculture, SEC Filing, Earnings, EBITDA, Mosaic Fertilizantes, Ma'aden, Biosciences, Mining, Commodities, Global Demand, Brazil Agriculture

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.